EP 2303252 A1 20110406 - COMPOUNDS FOR THE TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE
Title (en)
COMPOUNDS FOR THE TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE
Title (de)
VERBINDUNGEN ZUR BEHANDLUNG DES METABOLISCHEN SYNDROMS UND VON INSULIN-RESISTENZ
Title (fr)
COMPOSÉS POUR LE TRAITEMENT DU SYNDROME MÉTABOLIQUE ET DE LA RÉSISTANCE À L'INSULINE
Publication
Application
Priority
- AT 2009000200 W 20090515
- AT 7812008 A 20080515
Abstract (en)
[origin: WO2009137859A1] The present invention provides a compound comprising an ellagic acid moiety, such as ellagic acid itself, ellagitannins and ellagic acid glycosides - as well as plant extracts comprising the same, for the treatment or prevention of Metabolic Syndrome or non-diabetic insulin resistance.
IPC 8 full level
A61K 31/185 (2006.01); A61K 31/366 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 31/185 (2013.01); A61K 31/366 (2013.01); A61P 3/10 (2017.12)
Citation (search report)
See references of WO 2009137859A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
DOCDB simple family (application)
AT 2009000200 W 20090515; EP 09745281 A 20090515